Traditional immunohistochemical or RNA sequencing methods primarily reflect overall MSLN expression levels in tumor tissues and fail to distinguish whether expression originates from tumor cells themselves or other cell subpopulations within the tumor. This evidence concerns the gene MSLN and neoplasm.